Clinical Trial Update: Methylene Blue as a Third-line Vasopressor in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating methylene blue as a third-line vasopressor for septic shock is currently in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Carilion Clinic | Conditions: Septic Shock | Phase 2 | Status: UNKNOWN